Can levetiracetam be co‑administered with Adderall (mixed amphetamine salts)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Levetiracetam Be Co-Administered with Adderall?

Yes, levetiracetam can be safely co-administered with Adderall (mixed amphetamine salts), as levetiracetam has no clinically significant drug-drug interactions with stimulants or other medications metabolized through cytochrome P450 pathways.

Pharmacokinetic Profile Supporting Safe Co-Administration

Levetiracetam has an exceptionally favorable drug interaction profile that makes it compatible with virtually all medications, including Adderall:

  • No cytochrome P450 involvement: Levetiracetam and its metabolites are neither inhibitors nor substrates of hepatic CYP450 isoforms, epoxide hydrolase, or UDP glucuronidation enzymes 1, 2
  • Minimal metabolism: The drug undergoes only minor hydrolysis of the acetamide group (24% of dose), with 66% excreted unchanged renally 2
  • No enzyme induction or inhibition: Unlike older antiepileptic drugs, levetiracetam does not induce or inhibit metabolic pathways that would affect other medications 1

Clinical Evidence Base

The FDA drug label explicitly states that levetiracetam has "no known interactions" with multiple drug classes and specifically notes that "levetiracetam is unlikely to produce, or be subject to, pharmacokinetic interactions" 2. Clinical pharmacokinetic studies evaluated potential interactions with phenytoin, valproate, warfarin, digoxin, oral contraceptives, and probenecid—none showed clinically significant interactions 2.

Practical Considerations

While the pharmacokinetic interaction risk is negligible, monitor for:

  • Additive CNS effects: Both medications can affect alertness, though in opposite directions (levetiracetam may cause somnolence in 12-15% of patients 2, while Adderall is a stimulant)
  • Psychiatric symptoms: Levetiracetam carries risk for behavioral adverse effects including anxiety (16.5%), agitation (10.3%), and depression (9.6%) 3. These may be more apparent in patients taking stimulants
  • Seizure threshold: Amphetamines can theoretically lower seizure threshold, though this is rare at therapeutic doses

Key Caveats

The only scenario requiring dose adjustment for levetiracetam involves renal impairment (not drug interactions). If creatinine clearance is <80 mL/min, reduce levetiracetam dosing by 40-60% depending on severity 2. This is unrelated to Adderall co-administration but important for overall management.

Bottom line: No dose adjustments are needed when combining these medications based on drug-drug interaction concerns. The combination is pharmacokinetically safe 1, 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.